Lawyers Şamil Argun

Şamil Argun

Şamil Argun

CBC Law Firm

Şamil provides legal support to local and international clients in the life sciences & healthcare industry, advising on corporate and contentious issues. His work mostly focuses on compliance & business ethics, corporate & commercial law, and data protection law.

Şamil collaborates with senior team members on client correspondence, filing petitions, report writing, and liaising with government offices. In addition, his duties also include drafting and negotiating commercial agreements in the life sciences & healthcare industry.

Previously, Şamil worked as an intern in a boutique law firm focused on commercial law, maritime law, employment, and criminal law. Additionally, he has experience in the fields of ethics & compliance interning in Eli Lilly where he supported the local and global teams on various matters.


Practice Areas & Work Department

Corporate & Commercial

Intellectual Property

Regulatory & Compliance

Litigation & Dispute Resolution

Life Sciences & Healthcare


Languages

English

Turkish


Education

Istanbul University, LL.B. 2022

Türkiye İlaç ve Tıbbi Cihaz Kurumu Tanıtım Yönetmeliği Taslağı İkinci Kez Görüşe Açıldı

Türkiye Tıbbi İlaç ve Tıbbi Cihaz Kurumu’nun resmi internet sitesinde, 23.09.2024 tarihinde yayımlanan duyuruya göre, daha önce dış görüşe sunulan “Beşerî Tıbbi Ürünlerin ve Özel Tıbbi Amaçlı Gıdaların Tanıtım Faaliyetleri Hakkında Yönetmelik” taslağı için alınan görüşler doğrultusunda yeni taslak yayımlanarak ikinci kez dış görüşe açılmıştır.

26.09.2024

Access to Orphan Drugs in Türkiye: A Guide for Foreign Pharmaceutical Companies

This article provides a comprehensive guide on accessing orphan drugs in Türkiye, covering the Named Patient Program (NPP) and the Compassionate Use Program (CUP). It offers critical insights for foreign pharmaceutical companies on navigating these pathways to enter the Turkish market.

02.09.2024

EU Report: Antitrust Enforcement for Broader Pharmaceutical Access – Strengthening Compliance Amid Robust Measures

Explore the EU antitrust impact on pharmaceuticals (2018-2022). The recent report underscores the pivotal role of antitrust measures—promoting fair medicine prices, addressing anticompetitive practices, and shaping the future of pharmaceutical enforcement in Europe. In times of robust enforcement in both the EU and Türkiye, strategic compliance becomes imperative, providing pharmaceutical companies with a competitive edge.

23.02.2024

The Turkish Pharmaceutical Industry's Regulatory Landscape

The pharmaceutical industry in Turkey has great potential and is notable for its high-tech manufacturing capability. The industry currently ranks 7th in Europe and 16th in the world, in terms of market size, according to industry reports.[

09.03.2023
Load More
Ready to stay ahead of the curve?
Share your interest anonymously and let us guide you through the informative articles on the hottest legal topics.
|
Successful Your message has been sent